Public Assessment Report of over-the-counter stimulant laxatives: benefit-risk review
Public Assessment Report (PAR) discussing new risk minimisation measures which are being put into place for certain over-the-counter (OTC) stimulant laxatives.
Documents
Details
We continually review the safety of all medicines in the UK and inform healthcare professionals and the public of the latest updates.
In our Public Assessment Reports, we discuss evidence-based assessments of safety issues for a particular drug or drug class, and changes made to the product information on the basis of this evidence which will help safeguard public health.
This PAR covers new risk minimisation measures for over-the-counter (OTC) stimulant laxatives (bisacodyl, senna and sennosides (isolated as calcium salts) and sodium picosulfate) that are used for the treatment of constipation.